Skip to main content
. 2015 Mar 10;14:108. doi: 10.1186/s12936-015-0620-8

Figure 1.

Figure 1

Subject disposition (Cohort 2). AE = adverse event, AL = artemether-lumefantrine, AZCQ = azithromycin-chloroquine fixed-dose combination, MITT = modified intent-to-treat, PP = per protocol. *Includes 1 subject who discontinued treatment due to an AE.